Payment overview · 2025
General Payments
$52.14
3 reported records · 1 companies
Healthcare provider profile · identity verified
Pasquale Picco, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease · HORNELL, NY · NPI 1598719460
Verified facts
What the public records show
CMS Open Payments records show Pasquale Picco, M.D. received $52.14 in general payments during 2025 across 3 reported records.
Insmed, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Insmed, Inc. | Unresolved — no canonical attribution shown | $52.14 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $52.14 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Brinsupri Normalized: brinsupri |
Drug | Insmed, Inc. | $52.14 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1093 | 302 |
| Lisinopril | Lisinopril | 692 | 191 |
| Levothyroxine Sodium | Levothyroxine Sodium | 500 | 122 |
| Metoprolol Succinate | Metoprolol Succinate | 498 | 134 |
| Amlodipine Besylate | Amlodipine Besylate | 488 | 131 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 409 | 152 |
| Pantoprazole Sodium | Pantoprazole Sodium | 387 | 119 |
| Omeprazole | Omeprazole | 383 | 111 |
| Ezetimibe | Ezetimibe | 357 | 103 |
| Breo Ellipta | Fluticasone/Vilanterol | 345 | 95 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 331 | 68 |
| Prednisone | Prednisone | 312 | 119 |
| Montelukast Sodium | Montelukast Sodium | 306 | 94 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 301 | 84 |
| Losartan Potassium | Losartan Potassium | 295 | 73 |
| Hydrochlorothiazide | Hydrochlorothiazide | 287 | 75 |
| Alendronate Sodium | Alendronate Sodium | 270 | 93 |
| Metformin Hcl | Metformin Hcl | 240 | 67 |
| Potassium Chloride | Potassium Chloride | 240 | 71 |
| Glipizide Er | Glipizide | 231 | 63 |
| Simvastatin | Simvastatin | 230 | 69 |
| Spiriva Respimat | Tiotropium Bromide | 213 | 56 |
| Eliquis | Apixaban | 207 | 47 |
| Azithromycin | Azithromycin | 198 | 46 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 185 | 66 |
| Furosemide | Furosemide | 183 | 56 |
| Tamsulosin Hcl | Tamsulosin Hcl | 181 | 54 |
| Fluticasone Propionate | Fluticasone Propionate | 178 | 54 |
| Roflumilast | Roflumilast | 177 | 42 |
| Gabapentin | Gabapentin | 174 | 49 |
| Meloxicam | Meloxicam | 174 | 55 |
| Metoprolol Tartrate | Metoprolol Tartrate | 171 | 50 |
| Trazodone Hcl | Trazodone Hcl | 166 | 45 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 154 | 34 |
| Alprazolam | Alprazolam | 142 | 21 |
| Warfarin Sodium | Warfarin Sodium | 142 | 35 |
| Escitalopram Oxalate | Escitalopram Oxalate | 137 | 37 |
| Doxazosin Mesylate | Doxazosin Mesylate | 130 | 31 |
| Incruse Ellipta | Umeclidinium Bromide | 129 | 34 |
| Atenolol | Atenolol | 128 | 31 |
| Duloxetine Hcl | Duloxetine Hcl | 128 | 34 |
| Torsemide | Torsemide | 119 | 37 |
| Trulicity | Dulaglutide | 115 | 20 |
| Famotidine | Famotidine | 110 | 33 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 110 | 30 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 106 | 26 |
| Cefuroxime | Cefuroxime Axetil | 104 | 87 |
| Xarelto | Rivaroxaban | 101 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 100 | 30 |
| Metformin Hcl Er | Metformin Hcl | 97 | 30 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 93 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 88 | 11 |
| Allopurinol | Allopurinol | 87 | 25 |
| Doxycycline Hyclate | Doxycycline Hyclate | 85 | 70 |
| Tramadol Hcl | Tramadol Hcl | 76 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 73 | 20 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 73 | 21 |
| Rybelsus | Semaglutide | 67 | 18 |
| Sertraline Hcl | Sertraline Hcl | 67 | 19 |
| Spiriva Handihaler | Tiotropium Bromide | 67 | 15 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 66 | suppressed |
| Januvia | Sitagliptin Phosphate | 66 | 23 |
| Jardiance | Empagliflozin | 66 | 18 |
| Carvedilol | Carvedilol | 64 | 19 |
| Symbicort | Budesonide/Formoterol Fumarate | 63 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 62 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 62 | 18 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 58 | 26 |
| Novolog Flexpen | Insulin Aspart | 56 | 14 |
| Spironolactone | Spironolactone | 56 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 54 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 54 | 13 |
| Arnuity Ellipta | Fluticasone Furoate | 52 | 15 |
| Mometasone Furoate | Mometasone Furoate | 51 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 49 | 12 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 48 | 48 |
| Enalapril Maleate | Enalapril Maleate | 47 | suppressed |
| Ethambutol Hcl | Ethambutol Hcl | 47 | suppressed |
| Pregabalin | Pregabalin | 46 | suppressed |
| Invokana | Canagliflozin | 43 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 40 | 13 |
| Benazepril Hcl | Benazepril Hcl | 39 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 37 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 37 | 12 |
| Pirfenidone | Pirfenidone | 36 | suppressed |
| Ramipril | Ramipril | 36 | suppressed |
| Desloratadine | Desloratadine | 35 | suppressed |
| Nystatin | Nystatin | 35 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 35 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 33 | 16 |
| Fluconazole | Fluconazole | 32 | 21 |
| Glimepiride | Glimepiride | 32 | suppressed |
| Synthroid | Levothyroxine Sodium | 32 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 32 | 11 |
| Ozempic | Semaglutide | 31 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 30 | 19 |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Rifampin | Rifampin | 27 | suppressed |
| Finasteride | Finasteride | 26 | suppressed |
| Gemfibrozil | Gemfibrozil | 25 | suppressed |
| Irbesartan | Irbesartan | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Nitroglycerin | Nitroglycerin | 25 | 15 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 24 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 24 | 14 |
| Levofloxacin | Levofloxacin | 23 | 20 |
| Nucala | Mepolizumab | 23 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 22 | 19 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Colchicine | Colchicine | 20 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 20 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 19 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 19 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 19 |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Repatha Sureclick | Evolocumab | 19 | suppressed |
| Trospium Chloride | Trospium Chloride | 19 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 18 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 18 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 18 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Klor-Con M20 | Potassium Chloride | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 16 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Baclofen | Baclofen | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Clonazepam | Clonazepam | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Dupixent Pen | Dupilumab | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Zolmitriptan | Zolmitriptan | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Hydromorphone Er | Hydromorphone Hcl | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Jantoven | Warfarin Sodium | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Tezspire | Tezepelumab-Ekko | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $52.14 · 3 records | Insmed, Inc. | Brinsupri | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error